These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20974866)

  • 1. Regulation of mprF by antisense RNA restores daptomycin susceptibility to daptomycin-resistant isolates of Staphylococcus aureus.
    Rubio A; Conrad M; Haselbeck RJ; G C K; Brown-Driver V; Finn J; Silverman JA
    Antimicrob Agents Chemother; 2011 Jan; 55(1):364-7. PubMed ID: 20974866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance.
    Ernst CM; Slavetinsky CJ; Kuhn S; Hauser JN; Nega M; Mishra NN; Gekeler C; Bayer AS; Peschel A
    mBio; 2018 Dec; 9(6):. PubMed ID: 30563904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.
    Pillai SK; Gold HS; Sakoulas G; Wennersten C; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2223-5. PubMed ID: 17404001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Multiple Single-Nucleotide Polymorphisms Within mprF on Daptomycin Resistance in Staphylococcus aureus.
    Yang SJ; Mishra NN; Kang KM; Lee GY; Park JH; Bayer AS
    Microb Drug Resist; 2018 Oct; 24(8):1075-1081. PubMed ID: 29381428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of mprF in daptomycin-nonsusceptible Staphylococcus aureus strains.
    Yang SJ; Xiong YQ; Dunman PM; Schrenzel J; François P; Peschel A; Bayer AS
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2636-7. PubMed ID: 19289517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and genotypic correlates of daptomycin-resistant methicillin-susceptible Staphylococcus aureus clinical isolates.
    Kang KM; Mishra NN; Park KT; Lee GY; Park YH; Bayer AS; Yang SJ
    J Microbiol; 2017 Feb; 55(2):153-159. PubMed ID: 28120188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA).
    Thitiananpakorn K; Aiba Y; Tan XE; Watanabe S; Kiga K; Sato'o Y; Boonsiri T; Li FY; Sasahara T; Taki Y; Azam AH; Zhang Y; Cui L
    Sci Rep; 2020 Sep; 10(1):16107. PubMed ID: 32999359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causal role of single nucleotide polymorphisms within the mprF gene of Staphylococcus aureus in daptomycin resistance.
    Yang SJ; Mishra NN; Rubio A; Bayer AS
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5658-64. PubMed ID: 24002096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-genome sequencing identifies MprF mutations in a genetically diverse population of daptomycin non-susceptible Staphylococcus aureus in Australia.
    Lim C; Coombs GW; Daley DA; Shoby P; Mowlaboccus S
    Int J Antimicrob Agents; 2024 May; 63(5):107144. PubMed ID: 38494147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective
    Freeman CD; Hansen T; Urbauer R; Wilkinson BJ; Singh VK; Hines KM
    mSphere; 2024 Jun; 9(6):e0011524. PubMed ID: 38752757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged Exposure to β-Lactam Antibiotics Reestablishes Susceptibility of Daptomycin-Nonsusceptible Staphylococcus aureus to Daptomycin.
    Jenson RE; Baines SL; Howden BP; Mishra NN; Farah S; Lew C; Berti AD; Shukla SK; Bayer AS; Rose WE
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32601160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
    Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S
    Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus.
    Friedman L; Alder JD; Silverman JA
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2137-45. PubMed ID: 16723576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of resistance to daptomycin in Staphylococcus aureus.
    Gómez Casanova N; Siller Ruiz M; Muñoz Bellido JL
    Rev Esp Quimioter; 2017 Dec; 30(6):391-396. PubMed ID: 29082727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.
    Baltch AL; Ritz WJ; Bopp LH; Michelsen PB; Smith RP
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1559-62. PubMed ID: 17283190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis.
    Julian K; Kosowska-Shick K; Whitener C; Roos M; Labischinski H; Rubio A; Parent L; Ednie L; Koeth L; Bogdanovich T; Appelbaum PC
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3445-8. PubMed ID: 17620372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus.
    Patel D; Husain M; Vidaillac C; Steed ME; Rybak MJ; Seo SM; Kaatz GW
    Int J Antimicrob Agents; 2011 Nov; 38(5):442-6. PubMed ID: 21840181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LC-MS/MS characterization of phospholipid content in daptomycin-susceptible and -resistant isolates of Staphylococcus aureus with mutations in mprF.
    Rubio A; Moore J; Varoglu M; Conrad M; Chu M; Shaw W; Silverman JA
    Mol Membr Biol; 2012 Feb; 29(1):1-8. PubMed ID: 22276671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation in the vraS gene of Staphylococcus aureus contributes to reduce susceptibility against daptomycin.
    Su J; Iehara M; Yasukawa J; Matsumoto Y; Hamamoto H; Sekimizu K
    J Antibiot (Tokyo); 2015 Oct; 68(10):646-8. PubMed ID: 25899124
    [No Abstract]   [Full Text] [Related]  

  • 20. Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides.
    Bayer AS; Mishra NN; Chen L; Kreiswirth BN; Rubio A; Yang SJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4930-7. PubMed ID: 26055370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.